In the case of metabolic disorders, such as T2D, HbA1c is a crucial glycemic control and cognitive decline biomarker [16,17], whereas plasma GFAP and NfL are neuroinflammation and axonal damage indicators in T2D and obesity [24]. Here, NEFL is linked to metabolic disease.